Xconomy: Raleigh-Durham top stories News, Articles and Opinions

Results for “”

Entry	Author	Date	Location
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More	Alex Lash	07/12/19	National
Trump Kills His Administration’s Plan to End Secret Drug Rebates	Alex Lash	07/11/19	National
How Do YOU Think the Internet Will Evolve? A Sampling of Your Tweets	Wade Roush	07/09/19	National
Future of the Internet: What Scares Networking Pioneer Radia Perlman	Wade Roush	07/08/19	National
Why Bob Metcalfe Is an Optimist About the Internet	Wade Roush	07/08/19	National
Bio Roundup: Duchenne Race, Warren v. Gottlieb, A $599 Genome & More	Ben Fidler	07/05/19	National
The Next Internet: Usability Guru Don Norman Calls for Starting Over	Wade Roush	07/03/19	National
Special Report 2069: Predicting the Internet’s Next 50 Years	Wade Roush	07/02/19	National
Tracing the ARPANET Roots of the Internet’s Cybersecurity Crisis	Brian Dowling	07/02/19	National
As Cities Ban Face Recognition, Body-Cam Firm Axon Also Nixes It	Bernadette Tansey	06/28/19	San Francisco
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More	Alex Lash	06/28/19	National
What’s Worth $34B? IBM Gets OK in Europe for Acquisition of Red Hat	David Holley	06/27/19	New York
AbbVie to Pay $63B for Allergan to Prepare for Life Without Humira	Ben Fidler	06/25/19	Detroit Ann Arbor
Review: Inside the House of Lies at Theranos	Wade Roush	06/24/19	National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More	Frank Vinluan	06/21/19	National
Four More Through the IPO Door as Life Science Firms Raise $465M	Frank Vinluan	06/20/19	National
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More	Ben Fidler	06/14/19	National
IPO Scorecard: CrowdStrike Gains 70 Percent on First Trading Day	Bernadette Tansey	06/12/19	San Francisco
With Yale Tech and $12M, Artizan Aims for Root Cause of Gut Disease	Frank Vinluan	06/10/19	Boston
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More	Alex Lash	06/07/19	National
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More	Alex Lash	06/05/19	National
Bayer and Arvinas Join Forces in $115M Pharma & Ag Research Alliance	Frank Vinluan	06/04/19	Boston
Study: Gene Edits in CRISPR Babies Could Boost Risk of Earlier Death	Alex Lash	06/03/19	National
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More	Frank Vinluan	05/31/19	National
Quantum Computing 101: Brilliant, Google, Microsoft Training Workers	Bernadette Tansey	05/31/19	San Francisco
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?	Alex Lash	05/30/19	National
Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects?	Ben Fidler	05/29/19	National
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M	Ben Fidler	05/24/19	National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More	Alex Lash	05/24/19	National
Sebastian Thrun and Udacity Launch New Self-Driving Nanodegree	Bernadette Tansey	05/21/19	San Francisco
Page 1 of 27	next page »